| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |